Company / PP&E per Share
BioMarin Pharmaceutical PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$4.95
FY2025
5-year range
$4.95 / $5.76
FY2021-FY2025
Trend
-9.4%
vs FY2024
Sector context
#17 of 191
Health Care
What the data says
Among 191 Health Care companies, BioMarin Pharmaceutical is in the top 9% for pp&e per share. PP&E per Share has declined for 3 consecutive years, from $5.76 in FY2022 to $4.95 in FY2025.
Based on SEC 10-K filings.
4.95 in FY2025 with a 5-year CAGR of -2.7%. Top quartile in the Health Care sector.
Declined from $5.65 to $4.95 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -4.9%
- 5-Year CAGR
- -2.7%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 191This company $4.95 Sector average $22.34
▼
-77.8% below sector average
Key checks
Key Insights
- BioMarin Pharmaceutical's pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 9.4% year-over-year.
- Ranks #17 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.95 | -9.4% |
| FY2024 | $5.47 | -3.3% |
| FY2023 | $5.65 | -1.9% |
| FY2022 | $5.76 | +1.2% |
| FY2021 | $5.70 | +0.3% |
| FY2020 | $5.68 | +1.1% |
| FY2019 | $5.62 | +5.6% |
| FY2018 | $5.32 | +4.4% |
| FY2017 | $5.10 | +10.2% |
| FY2016 | $4.63 | +6.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026